Cosmo Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Cosmo Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cosmo Pharmaceuticals N.V.
Access all reports
Cosmo Pharmaceuticals N.V. is a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and medical devices for endoscopy procedures. The company engages in research, development, manufacturing, and commercialization of drug products and diagnostics. It serves both prescription drug and medical technology markets. The company is headquartered in Dublin, Ireland, and its shares are listed on the SIX.
Key slides for Cosmo Pharmaceuticals N.V.
H1 2024
Cosmo Pharmaceuticals N.V.
H2 2024
Cosmo Pharmaceuticals N.V.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
COPN
Country
🇨🇭 Switzerland